5420 Feltl Road
United States - Map
Uroplasty, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of voiding dysfunctions. The company principally offers Urgent PC Neuromodulation system, a minimally-invasive, neuromodulation system that delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder (OAB) and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique, a urethral bulking agent for the treatment of adult female stress urinary incontinence due to intrinsic sphincter deficiency, as well as for the treatment of male stress incontinence, fecal incontinence, vocal cord rehabilitation, and vesicoureteral reflux. It also provides PTQ Implants, which offers a minimally-invasive, soft-textured permanent implant for treatment of fecal incontinence; and VOX Implants, a silicone elastomer bulking material for vocal cord rehabilitation applications, as well as engages in the distribution of wound care products. The company sells its products primarily to urologists, urogynecologists, and gynecologists through a direct sales organization in the United States, the United Kingdom, and the Netherlands, as well as through distributors in other markets. Uroplasty, Inc. was incorporated in 1992 and is headquartered in Minnetonka, Minnesota.
|Mr. Robert E. Kill ,
Chief Exec. Officer, Pres and Director
|Ms. Susan Hartjes Holman ,
Chief Operating Officer and Corp. Sec.
|Mr. Larry Heinemann ,
VP of Corp. Devel.
|Ms. Nancy A. Kolb ,
VP of Global Marketing
|Mr. Brett A. Reynolds Buch,
Chief Financial Officer and Sr. VP
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|